Drug policies have traditionally sought to suppress supply and deter use through the application of punitive laws. Today, there is a growing recognition that these drug policies have not only failed to reach their objectives but have resulted in a great deal of collateral damage. Drug policy must be reformed to focus on health, human rights and development objectives, with the aim of making the market less harmful rather than necessarily reducing its size.
IDPC and GDPO unpick key issues raised by the 2019 World Drug Report through the lens of public health, including the expansion of regulated cannabis markets, the non-medical use of tramadol in Africa and challenges related to data-collection.
This report by the Parliamentary Committee on Drug Policy recognises evidence that UK drugs policy is failing, and that the level of drug related deaths has now risen to the scale of public health emergency.